Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
as far as hgen goes well same clowns different car.
We know Nader certainly hoped and desired to have the results last week. What is the prognosis now?
Take a moment and just think that RLFT market cap is same as HGEN right now. It is clear OTC manipulation there. CYDY has same as well. Eventually they both will fade just in time for 2/26 with HGEN chat and FDA meeting!
You don’t lose money unless you sell.
RLFTF ended their trial 9 days after CYDY and their topline results came today. CYDY has the simplest primary endpoint to compute: mortality. And yet, they withhold their topline results. Clearly, CYDY is delaying their mediocre results. HGEN is the best play now of the Covid stocks. Their stock price will surely double or triple in the leadup to trial results the same way RLFTF and CYDY did. Profit on people's excitement instead of losing on poor trial results.
What variables were you looking at to catch this before today's action?
Move on...you're not changing anyone's mind on this board...and for the record, I don't get upset over folks with I'll intentions. I will sit back and get a kick from your attempts to change peoples minds...lol
How much do you have invested?
If the results are bad, why begin an inhaler study and make it a news story.
At some point this week or next week, the stock price will start to skyrocket in anticipation of trial results. It will gain $1 or $2 each day. Hopefully, today's rise to $22 is the beginning of the rise. Although, it'll take getting up to $24-$25 for it to be a certainty that the rise has started.
They have 0% chance to get an EUA at this juncture. The study was already tiny at 195 patients. It makes sense to expand the trial and change the primary endpoint to length of hospital stay.
The stock is about to go down 30%-50% and Andy2018 and JerryWhyInvest only see sunshine and roses.
He said Javitt had some confusion as to a call versus news release.....
I've felt since September that HGEN's share price has been kept down by big investor(s) selling. I don't blame them for selling. Most of us who have made big gains have sold stock to lock in gains. They've made sure to not let the sp crater but they've kept us in a 3 dollar range most of the time. But that will soon end. Any big investor is going to want to let the share price rise in the weeks before trial results. Share price will go higher with good trial results so it makes sense to want to start out with a higher share price to launch from. Both RLFTF and CYDY tripled in stock price in the leadup to trial results. HGEN is next.
Why is the stock price up? That press release was nothing burger. The stock price should have decayed a bit with the further delay of trial results. Does anyone have an explanation?
BECAUSE they wouldn't move forward with that study if intravenous VIP (RLF-100) wasn't a slam dunk
Can anyone explain what we're seeing today with RLF? I understand with OTC we're going to have a lack of consistency but I'm baffled by todays performance...any thoughts?
I sold. See you guys at the next dip.
Why do you say the trial results are "delayed"? Relief never gave any specific date for the results. Only "late Jan./early Feb."
Insiders already own gazillion shares; pps is going down currently due to MMs or Daytraders.
So what will happen to the stock price if the data is good but not good enough for an EUA and the FDA tells them to expand the number of patients in the trial? 195 patients is tiny. Our doppelganger, RVVTF, has 1,000 patients in their Covid trial.
There must he other reasons for delaying the readout.
FYI. It's up on the Swiss exchange and the drop in price here hasn't affected the Swiss price.
Today's opening is not encouraging. Insiders should be buying if trial data is good. It is now going to slowly bleed out until data is released.
This news is significant enough that they'll halt trading and announce it when the Swiss and US markets are both open to give us equal opportunity.
I always work on the assumption that news will come later than they say it will. I don't know why biotech execs are always saying results will come sooner instead of later. Missing even vague deadlines drives shareholders crazy. Maybe they truly believe the timeframe they say but then bureaucratic things pop up and delay things. So I'm hoping that results come by Wednesday. But if I wake up in the middle of the night tonight, you can bet your bottom dollar I'll be checking if there is news.
3DICON had 2 reverse splits in their timeline.
I have been here since July and imo the swiss ticker controls us
One of my other penny stock had a merger with a reverse split 3 years ago.
BRPA rose 18% in after hours trading tonight. Tomorrow can't come soon enough!
It was natural that some would take profits when it rose to $.76. Those sellers are now gone and can't sell again. Usually when a stock rises like it did today and then falls, it will bounce right back up in the next trading day. In other words, there is a high probability that the stock will be $.76 or higher tomorrow.
BRPA is up 20% in after hours trading! Tomorrow should be huge for RLFTF!
Wrong as long as we reduce hospital days by one day , we will get the remdesthasir approval . Lol
It is nice seeing the stock price rebound over the last hour. Remember, when large shareholders want to increase their holdings, they will often make the stock tumble for a couple of days first by selling. Then they will scoop up the shares being sold by weak hands. This kind of manipulation is common in the small cap biotech world. Patience is a must.
Does anyone have an explanation for today's rise from $4.40 to $5.38? Was it Patterson's presentation that caused the bump?
NP said- No unblinding this week, maybe next week---
NP at ~4:50 mark in the video = "Remember, we got dragged into the COVID-19" - Not a good statement to make to investors waiting on a trial outcome. You can hear it in his voice, he is going to blame this on someone else.
compiled in the safety reports
I agree. Once the trial is unblinded usually take the CRO at least two weeks to run the numbers.
He appeared tired, but I'm sure he's put in a lot of hours on CD12